Connect with us

Hi, what are you looking for?

Science

Inventor Creates Affordable Multi-Channel Pipette for Experiments

The cost of drug development often stems from the extensive experimentation required, with the design of a single new drug necessitating the synthesis and testing of hundreds or thousands of compounds. To tackle this challenge, a new approach to experimentation is emerging. Triggy, an inventor, has developed a 96-channel multi-pipette that significantly reduces costs, allowing for parallel experimentation at a fraction of the professional price.

Traditional multi-channel pipettes can be prohibitively expensive, often retailing for as much as $18,000. In contrast, Triggy constructed his own device for approximately $300. This innovative pipette features an eight-by-twelve grid of syringes, allowing it to collect and dispense liquids into multiple vessels simultaneously. The syringes are secured by a plate, while their plungers are mounted to another plate activated by four stepper motors.

Design and Functionality of the Multi-Pipette

To accommodate the use of multi-well plates, the syringe mechanism must be able to move vertically. Triggy achieved this by mounting the lower plate to a series of parallel levers and gears. By manually lifting the lever, he can raise the syringes to insert or remove a multi-well plate as needed.

The entire structure is enclosed in an aluminum extrusion frame, with heat-shrink tubing enabling pipette tips to fit on the syringes. While Triggy did not have a sophisticated method to verify the accuracy of the multi-pipette, initial tests yielded encouraging results. He demonstrated its capabilities by 3D-printing two plates with parallel channels, filling them with varying concentrations of watercolors. When the multi-pipette was used to combine the colors from different channels, it produced a smooth gradient across the wells.

This device allows researchers to test up to 96 small variations of a single experiment simultaneously, enhancing efficiency in the laboratory. Despite the advantages of Triggy’s invention, it is important to note that this machine is intended for home experimentation. The precision and certifications required for medical development remain significant hurdles, meaning the device would need extensive testing before being deemed reliable for critical applications.

The Bigger Picture in Drug Development

The high costs associated with drug development can be attributed to several factors, one of which is the need for extensive experimentation. Triggy’s multi-channel pipette offers a more accessible tool for researchers and hobbyists alike, potentially expanding the scope of experimentation in both academic and home settings.

The innovations in miniaturization and automation have made large-scale biology experiments increasingly feasible, leading to a growing trend in DIY lab equipment. While Triggy’s multi-pipette is an impressive feat of engineering, it serves as a reminder of the balance between affordability and the rigorous standards required in professional scientific research.

This development highlights the potential for individuals to contribute to scientific experimentation, albeit with the understanding that any device used for critical research must undergo thorough evaluation. As the landscape of drug development continues to evolve, innovations like Triggy’s multi-pipette may play a significant role in shaping the future of experimentation.

Trending

You May Also Like

Top Stories

UPDATE: NASA is inviting everyone on Earth to send their name to the Moon aboard the Artemis II mission, set to launch no later...

Science

The prophecies of the 16th-century French astrologer Nostradamus continue to captivate audiences as we approach 2026. His cryptic insights, compiled in his 1555 publication...

Top Stories

UPDATE: Authorities have charged 27-year-old Steven Tyler Whitehead with murder following a tragic shooting that critically injured Kimber Mills, a senior cheerleader at Cleveland...

Top Stories

UPDATE: In a stunning turn of events, 18-year-old influencer Piper Rockelle has shattered the previous OnlyFans earnings record set by fellow content creator Sophie...

Top Stories

UPDATE: Pop superstar Ariana Grande is on the road to recovery after testing positive for COVID-19. Her brother, Frankie Grande, shared the encouraging news...

Sports

The UFC event in Abu Dhabi on July 26, 2025, featured a record-breaking performance from Steven Nguyen, who achieved an unprecedented feat by knocking...

Top Stories

URGENT UPDATE: Affordable motorcycle helmets under ₹1000 are now available for safety-conscious riders across India. With road safety becoming a pressing issue, these helmets...

Entertainment

**Kat Izzo Defends Relationship with Dale Moss Amid Controversy** Kat Izzo, a contestant from the reality series *Bachelor in Paradise*, publicly affirmed her relationship...

Entertainment

The upcoming Netflix series, Bon Appétit, Your Majesty, is making headlines due to a significant casting change just ten days before filming commenced. Originally...

Top Stories

UPDATE: Sydney Sweeney’s Baskin-Robbins advertisement is making waves online as backlash intensifies over her recent American Eagle campaign. Just days after critics condemned the...

Top Stories

UPDATE: Chicago Cubs designated hitter Kyle Tucker may have just played his last game for the team as free agency approaches. Following the Cubs’...

Lifestyle

Shares of **Amerant Bancorp** (NYSE:AMTB) received an upgrade from Wall Street Zen on March 10, 2024, transitioning from a hold rating to a buy...

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.